Latest Cancer News

FDA Approves Iobenguane I 131 (Azedra) for Rare Neuroendocrine Tumors (08-2-2018)
The US Food and Drug Administration (FDA) today approved Azedra (iobenguane I 131) for the treatment of pheochromocytoma or paraganglioma, which are rare neuroendocrine tumors of the adrenal gland and... Continue Reading

Tibsovo Approved for Treatment of Relapsed/Refractory Acute Myeloid Leukemia and an IGH1 Mutation (07-23-2018)
Tibsovo┬« (ivosidenib) has been granted approval from the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (R/R AML) with a... Continue Reading

FDA Approves Kisqali as Initial Endocrine Therapy for Advanced Breast Cancer (07-23-2018)
The U.S. Food and Drug Administration today approved Kisqali (ribociclib) in combination with an aromatase inhibitor for the treatment of pre/perimenopausal or postmenopausal women with hormone receptor... Continue Reading

More Cancer News

Locations

Alaska Oncology & Hematology, LLC
2925 DeBarr Road, Building D, Suite 300
Anchorage, Alaska 99508

Phone No. (907) 279-3155
Fax No. (907) 279-3154